Background The heart has been demonstrated not only to be a pumping organ but also an endocrine organ secreting atrial natriuretic peptide (ANP). We hypothesized that myocardial ischemia may affect ANP secretion and that reperfusion therapy for acute myocardial infarction can preserve endocrine function of the heart.
Background The heart has been demonstrated not only to be a pumping organ but also an endocrine organ secreting atrial natriuretic peptide (ANP). We hypothesized that myocardial ischemia may affect ANP secretion and that reperfusion therapy for acute myocardial infarction can preserve endocrine function of the heart.
Methods and Results Twenty patients with acute right ventricular infarction were examined who underwent reperfusion therapy on admission. These patients had proximal occlusion of the dominant right coronary artery involving the right atrial branches: 9 patients with successful reperfusion (SRP group) and the remaining 11 patients with unsuccessful reperfusion (URP group). Within 24 hours after the onset of infarction, a volume loading test was performed after reperfusion therapy with measurements for plasma ANP levels and hemodynamics. Before the volume loading test, the plasma ANP level and mean right atrial pressure were similar between these two R eperfusion therapy in acute myocardial infarction has been shown to salvage myocardial tissue' and to reduce mortality2 and ventricular irritability.3 This therapy also has been reported to result in a rapid improvement in right ventricular function4 and resolution of atrioventricular block complicated with acute inferior infarction.5 Recently, the heart has been demonstrated not only to be a pumping organ but also an endocrine organ secreting atrial natriuretic peptide (ANP). This peptide appears to influence circulatory homeostasis through vasoactive and natriuretic activities, which are clinically useful for the treatment of congestive heart failure. 6, 7 Acute right ventricular infarction is a unique clinical model to study both ANP secretion after acute myocardial infarction and the response of ANP secretion to volume loading, which is usually applied as a treatment in this setting. It is well known that hormone synthesis or release is an energy-dependent process and therefore sensitive to ischemia. Serra et a18 reported that the response of ANP release to volume loading was attenuated in patients with acute right ventricular infarction. However, because their study was performed in patients without reperfusion therapy, the effect of coronary groups. However, in the URP group, percent increase in ANP in response to volume loading was strikingly smaller (URP, 45±18% versus SRP, 133±25%; P<.O1) despite similar percent increase in mean right atrial pressure (URP, 100±46% versus SRP, 86±23%). The peak ANP level occurred significantly later in the URP group (69±16 hours) than in the SRP group (28+9 hours, P<.001) after the onset of infarction.
Conclusions The response of ANP release to volume loading is attenuated in patients with right ventricular infarction without coronary reperfusion. However, successful reperfusion induces a rapid recovery of cardiac endocrine function as well as its mechanical function. A sufficiently elevated plasma ANP level may be a useful predictor of hemodynamic improvement in patients with right ventricular infarction. (Circulation. 1994;89:558-566.)
Key Words * infarction * peptides * reperfusion reperfusion on ANP secretion has never been clarified. Therefore, the goal of this study was to examine our hypothesis that (1) myocardial ischemia affects ANP secretion, (2) reperfusion therapy for acute myocardial infarction can preserve endocrine function of the heart, and (3) this salvaged endogenous peptide is of some help to enhance the functional recovery process from acute right ventricular infarction.
Methods Study Patients
Patient selection is shown in Fig 1, 3 . A second cardiac catheterization was performed before hospital discharge in all patients except two in the RVI group in whom reperfusion therapy was unsuccessful on admission.
Therapeutic Choices
Volume loading therapy was the initial choice of treatment in patients with right ventricular infarction, in whom normal saline infusion was continued when the pulmonary capillary wedge pressure was <15 mm Hg. When volume loading therapy did not increase cardiac output or correct hypotension, dobutamine was infused at a starting rate of 1.0 ,ug kg`. min-1 and increased to a maximum of 10 jig kg`. min`. No vasodilator agent was administered to patients in the RVI group. When pulmonary capillary wedge pressure reached 18 mm Hg, a small amount of diuretic agent (furosemide, 5 mg) was sometimes used to prevent left heart failure. Blood Sampling and Hormonal Assays Blood samples were drawn from the pulmonary artery through a Swan-Ganz catheter into the tube containing ethylenediaminetetraacetic acid and aprotinin in the same manner as reported previously.11 Plasma was stored frozen immediately at -80°C in polyethylene tubes until assay. Plasma levels of ANP were determined by specific radioimmunoassay (Eiken Chemical Co) after extraction with octadecylsilane cartridges, as described previously.12 Samples from each patient were analyzed as a batch within 1 week after collection. Normal values in our institute were 29 to 74 pg/mL. Creatine phosphokinase was also measured at the same sampling point as ANP. The highest level of serial changes of plasma ANP was defined as peak ANP in the present study.
Statistical Analysis
Results were expressed as mean±1 SD. Differences in characteristics among patient groups were compared by oneway ANOVA or X2 analysis. Repeated-measures ANOVA was used for comparison of the serial data followed by the multiple comparison test. A value of P<.05 was considered significant.
Results

Comparison of Baseline Characteristics
In 9 of 20 patients in the RVI group, reperfusion therapy was successful, and its patency was verified at the chronic stage (SRP). In the remaining 11 patients, reperfusion therapy was unsuccessful (URP). Table 1 compares baseline characteristics of the SRP, URP, and control groups. There were no differences in age, sex, left ventricular ejection fraction, peak serum creatine phosphokinase, and pulmonary capillary wedge pressure on admission among those three groups. Systolic blood pressure and cardiac index were significantly lower, and right atrial pressure was higher in the RVI group than in the control group, which was compatible with the characteristics of right ventricular infarction. Although plasma ANP level on admission was higher in the RVI group than in the control group, the level was within the normal range (29 to 74 pg/mL) in 19 of 20 patients in the RVI group. Both the elapsed time to admission and the time to peak serum creatine phosphokinase were much longer in the URP than in the other two groups with successful reperfusion. Atrial tachyarrythmias and atrioventricular block were recorded more frequently in the URP group than in the other two groups, but the difference did not reach statistical significance.
Angiographic studies showed that all 20 patients in the RVI group had proximal occlusion near the ostium of the dominant right coronary artery involving right atrial branches as well as right ventricular branches. In the control group, right ventricular branch involvement was shown only in 3 patients (27%, P<.05 versus RVI). Volume Loading Test The initial volume loading test was performed at the acute stage, 14±6 hours after the onset of myocardial infarction. The results were summarized in Fig 3 ( To correct persistent hypotension, saline infusion was performed after the initial volume loading test in the URP group. Although right atrial pressure increased sufficiently due to saline infusion by 27±9 hours after the onset of myocardial infarction (equal to before dobutamine infusion), plasma ANP level remained disproportionately low (Fig 4) . During this period of hyposecretion of ANP, patients suffered from a low cardiac output and oliguria with a high right atrial pressure (Table 2 ). Both the systemic and the pulmonary vascular resistance abnormally increased. The upper panel of Fig 5 demonstrates a representative case in the URP group that shows the discrepancy between the increment in plasma ANP level and that in right atrial pressure with a low cardiac output condition. Because of the low cardiac output state, the administration of dobutamine was required in all 11 patients of the URP group (versus 0% in SRP or control, P<.01). During the steady state with dobutamine infusion (42±12 hours after the onset of infarction), ANP release remained unchanged (Fig 4 and Table 2 ). Cardiac output increased slightly, but its change was not statistically significant. Subsequently, plasma ANP level gradually increased and formed its peak at 69±16 hours after the onset of myocardial infarction. It is of note that the ratio of peak ANP value to mean right atrial pressure in the URP group (12 Patients' conditions on admission in the SRP group were similar to those observed in the URP group, ie, a low cardiac output and increased vascular resistance (Table 3) . Consequently, volume loading therapy with normal saline was also performed after the initial volume loading test. Because patients in the SRP group had a favorable response to volume loading therapy alone, they did not require dobutamine infusion. After volume loading therapy, plasma ANP levels reached peak value concomitantly with the increase in right atrial pressure (Fig 4) . Urine volume rate over 24 hours increased strikingly by eightfold, and cardiac output was augmented by 31% (Table 3 ). This increment in urine volume was disproportionately larger than that in cardiac output, suggesting that this increase in urine volume was due to a direct effect of ANP rather than the secondary effect of an increase in cardiac output. The lower panel of Fig 5 demonstrates a representative case in the SRP group showing that cardiac output and urine volume increased more quickly after the earlier peak of plasma ANP level compared with the case in the URP group shown in the upper panel.
Discussion
The present study has demonstrated that (1) the response of ANP release to volume loading was attenuated in patients with right ventricular infarction without coronary reperfusion and (2) successful coronary reperfusion preserved cardiac endocrine function from an ischemic insult.
Attenuated ANP Secretion in Right Ventricular Infarction
Atrial natriuretic peptide is synthesized and stored in atrial myocyte granules. It is rapidly induced and released within minutes and increases in plasma acutely by 10 to 15 pmol/L for each 1 mm Hg increment of atrial pressure. 13 However, in the present study, the blunted response to volume loading was observed after the onset of right ventricular infarction in patients without coronary reperfusion. This finding suggests that a pressure sensitivity of ANP release is attenuated in acute right ventricular infarction with an occluded right coronary artery. The mechanism of such attenuation is unclear. However, several explanations are possible, such as (1) a depletion of ANP storage caused by an excessive release, (2) a reduced rate of synthesis or translocation of ANP caused by right atrial ischemia or necrosis, or (3) a reduced compliance of the ischemic atrium.
A depletion of ANP has been reported to be due to a long-term pronounced ANP secretion under some conditions such as hypertension14"15 or chronic severe heart failure. 16 However, the condition in the present study was different from the previous reports because (1) all patients who had any diseases associated with chronic high plasma ANP levels were excluded from the study, (2) the initial volume loading test was performed soon after the onset of myocardial infarction, and (3) the plasma ANP level before the initial volume loading test remained within the normal range. Thus, it is unlikely that ANP storage is exhausted in patients of the present study.
It is well known that hormone synthesis or release is an energy-dependent process. 17 In the present study, all patients had right coronary artery occlusion near the ostium, suggesting the presence of right atrial ischemia or infarction.18 During ischemia, the production of high-energy phosphate declines and its stores deplete progressively.19 Thus, the decreased intracellular energy supply during atrial ischemia probably impairs the ability of ANP synthesis or translocation to the release site, which may play a role in the blunted response of this peptide release to volume loading.
Myocardial ischemia alters chamber compliance,20 which determines chamber volume at a given pressure. Atrial distension has been reported to be the primary mechanism controlling ANP release. 21 Therefore, the ischemic atria may have released less hormone because of a reduction in atrial compliance because less compli-ant atria-respond to a given pressure with a lesser degree of distension.
Pressure sensitivity of ANP secretion recovered a few days after the onset of myocardial infarction as demonstrated in Figs 3 Atrial natriuretic peptide has a natriuretic effect, which is highly dependent on sodium or water balance. Therefore, this endogenous peptide might serve as an important regulator to prevent excessive circulatory volume overload in right ventricular infarction.
A low cardiac output condition leads to activation of the vasoconstrictive neurohormonal system such as the renin-angiotensin-aldosterone system, arginine vasopressin, and the sympathetic nervous system. Although ANP is considered to be an ideal endogenous agent to counterbalance the detrimental effects of those vasoconstrictive systems,29-31 the vasodilatory effect of ANP seems to be modest even during peak ANP release in the present study. This is probably because the effects of ANP are masked by the stimulation of the more potent vasoconstrictive system.32,33 Our results also suggest that this peptide may cause vasodilation of the pulmonary vascular bed34 in right ventricular infarction, which is advantageous for right ventricular systolic performance.
Effects of Coronary Reperfusion on ANP Secretion
Reperfusion therapy has been shown to decrease infarct size' and to reduce mortality2 and ventricular irritability.3 For acute right ventricular infarction, reperfusion therapy is beneficial because it induces rapid improvement of right ventricular function4 or resolution of atrioventricular block.5 Furthermore, in the present study, we have shown that coronary reperfusion preserved cardiac endocrine function as well as its mechanical function. This preserved ANP secretion might help to maintain sodium-water excretion and promote vasodilation, which may contribute in part to the enhancement of the hemodynamic recovery after acute right ventricular infarction.
In the present study, patients without coronary reperfusion suffered from a refractory low cardiac output condition coupled with vasoconstriction during the phase of hyposecretion of ANP. However, such a detrimental condition associated with an ANP deficiency did not last long because of the delayed but spontaneous recovery of ANP synthesis or release. Like an exogenous ANP infusion for the treatment of congestive heart failure,67 enhanced ANP secretion appeared to have improved the hemodynamics of acute right heart failure. If a deficiency of ANP is continued, hemodynamic deterioration would be accelerated. Fig 6 shows one patient with acute right ventricular infarction without coronary reperfusion who was not entered into the study group because of a history of anterior nontransmural myocardial infarction. This patient died of severe low cardiac output on the sixth hospital day with a persistent failure of ANP release without responding to the high filling pressure. At autopsy, the right atrium was dilated and histological specimens revealed extensive necrosis of the atrial wall, suggesting irreversible endocrine failure of the right atrium. In a similar case, a patient who died of acute right ventricular infarction has been reported to be accompanied by the functional defect of ANP release.27 These findings support the hypothesis that persistent ANP deficiency may indicate a poor prognosis in patients with right ventricular infarction. Salvaging endocrine function by the reperfusion therapy may have a beneficial effect in these patients. Clinical Implications Robalino et a127 suggest that an elevated plasma ANP level may be used as an early diagnostic marker of right ventricular involvement. However, plasma ANP level would not be elevated soon after the onset of myocardial infarction if right atrial pressure remains within the normal range or if a secretion of ANP is impaired by the ischemic insult. Thus, it would be difficult to establish the diagnosis of right ventricular infarction only by the plasma ANP level. In contrast, the present study has shown that the hemodynamic improvement follows the occurrence of peak ANP (Fig 5 and Table 2 ), suggesting that an elevated ANP level can be used as a useful predictor of the functional recovery from acute right ventricular infarction.
The highest reported incidence of atrial infarction by the autopsy study is 42%. These findings suggest that reperfusion therapy contributes to the enhanced hemodynamic recovery by salvaging endocrine function as well as mechanical function.
